Getinge Value Chain Analysis
Fully Editable
Tailor To Your Needs In Excel Or Sheets
Professional Design
Trusted, Industry-Standard Templates
Pre-Built
For Quick And Efficient Use
No Expertise Is Needed
Easy To Follow
This Getinge Value Chain Analysis helps you understand how Getinge creates value across its support and primary activities in a clear, practical framework. This page already shows a real preview of the actual analysis, so you can review the style and content before buying. Purchase the full version to get the complete ready-to-use report.
Support Activities
Getinge's firm infrastructure is built on regulatory governance, quality systems, and global coordination, which are critical in medtech because product approvals, traceability, and risk controls decide market access. In 2025, Getinge reported net sales of SEK 33.3 billion, and that scale makes centralized compliance and quality control a core cost and control layer. This setup helps the Getinge value chain move products into hospitals and life science labs across many regions with fewer regulatory delays.
Getinge depends on engineers, manufacturing staff, clinical specialists, and field technicians to keep ICU, operating room, reprocessing, and biopharma systems working safely. In 2025, Getinge reported about SEK 34 billion in net sales, so skilled hiring and tight training directly support product quality, service uptime, and regulated customer workflows.
Getinge's Technology Development builds equipment and systems for intensive care, cardiovascular procedures, operating rooms, sterile reprocessing, and life science production. In 2025, the focus stayed on R&D that improves product safety, workflow efficiency, and compliance across all 5 application areas. That matters because the safer and more automated the kit, the less downtime and rework in hospitals and labs.
Procurement
Getinge sources precision parts, electronics, materials, and outsourced components from qualified suppliers to keep its regulated product lines stable and compliant. Strong procurement helps protect quality, reduce supply shocks, and support scale across medical devices where a single part delay can stop production. In 2025, that discipline matters even more as Getinge balances cost control with tighter supplier oversight and traceability.
Getinge's support activities in 2025 centered on compliance, skilled labor, R&D, and tight procurement, all of which keep regulated medtech production stable. Net sales were SEK 33.3 billion, so even small gains in quality control, training, and supplier traceability matter. This support base lowers approval risk, reduces downtime, and protects delivery flow.
| 2025 area | Key data |
|---|---|
| Net sales | SEK 33.3 billion |
| Scale | 5 application areas |
| Support focus | Compliance, talent, R&D, sourcing |
What is included in the product
Primary Activities
Getinge's inbound logistics is built around traceable intake checks for components, subassemblies, and materials before they reach regulated assembly lines. In 2025, that control matters because ISO 13485 and EU MDR expect full lot traceability and tight supplier control, which helps cut nonconformance, rework, and recall risk. One weak incoming part can stop an entire device batch.
In 2025, Getinge's operations turned designs into compliant healthcare and life science equipment by assembling, testing, validating, and configuring products for critical use.
This work supported net sales of about SEK 34 billion and helped protect quality in high-risk clinical and production settings.
For Getinge, Operations is the last mile between engineering and safe, ready-to-use devices.
Getinge ships finished systems through controlled channels, and it ties delivery to installation planning and spare-parts coordination so hospitals and biopharma customers get the right setup on time.
This matters because many of its products are high-value, regulated systems, so a missed delivery or wrong configuration can delay use and raise service costs.
Outbound logistics also supports after-sales uptime by routing critical spare parts with the same discipline as the original shipment.
Marketing and Sales
Getinge sells through direct teams and channel partners to hospitals, health systems, and life science facilities, so Marketing and Sales is built around consultative selling, not price alone. The pitch focuses on clinical outcomes, uptime, and workflow efficiency, which matters because device downtime can disrupt operating rooms and sterile processing. This approach supports premium systems and long service contracts.
Service
Getinge's service activity covers installation, maintenance, training, repairs, and lifecycle support across its installed base. This keeps critical systems running, cuts downtime, and helps hospitals avoid costly interruptions. Strong service also drives repeat business, because upgrades, parts, and long-term contracts often follow the original sale.
Getinge's primary activities in 2025 focused on turning regulated medical designs into finished devices, moving them to hospitals and biopharma sites, and keeping installed systems running. Operations anchored about SEK 34.2 billion in net sales, while sales and service supported uptime, repeat orders, and long-term customer ties. The chain is built for traceability, delivery accuracy, and repair speed.
| Activity | 2025 data |
|---|---|
| Net sales | SEK 34.2 bn |
| Core focus | Assembly, testing, service |
| Customer base | Hospitals, biopharma |
Preview the Actual Deliverable
Getinge Reference Sources
This is the actual Getinge Value Chain Analysis document you'll receive after purchase – no surprises, just the full professional version. The preview below is taken directly from the complete report, so what you see is exactly what you'll get. Once purchased, the full Getinge Value Chain Analysis becomes available for immediate download.
Frequently Asked Questions
Getinge creates value by connecting 4 support activities with 5 primary activities across its medical technology platform. The flow starts with regulated R&D and sourcing, moves through manufacturing and distribution, and ends with installation, training, and maintenance. That matters because its products serve 5 areas: intensive care, cardiovascular care, operating rooms, sterile reprocessing, and life science.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site - including articles or product references - constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.